GVR Report cover U.S. SNF Based Dialysis Market Size, Share & Trends Report

U.S. SNF Based Dialysis Market Size, Share & Trends Analysis Report By Region (Northeast, Southeast, Southwest, Midwest, West), And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-006-3
  • Number of Report Pages: 70
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2021
  • Forecast Period: 2023 - 2030 
  • Industry: Healthcare

Report Overview

The U.S. SNF based dialysis market size was valued at USD 2.8 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.22% from 2023 to 2030. The growth can be attributed to an increase in the prevalence of ESRD and a rise in demand for on-site dialysis in skilled nursing care by patients. As per the annual report of the U.S. Renal Data System 2022, around 780,500 individuals in the U.S. were suffering from ESRD in 2020, with around 96.9% among them being on dialysis. The population of patients requiring dialysis services is expected to reach 793,781 by 2022. Patients receiving traditional in-center dialysis services may face problems regarding cardiovascular or hemodynamic instability as well as transportation-related issues.

U.S. SNF based dialysis market size, by region, 2020 - 2030 (USD Billion)

Moreover, an ever-growing number of ESRD patients with multiple comorbidities, and age-related frailties may require complex skilled nursing facility (SNF) based care. In addition, the collaborations of SNF with external dialysis centers enable enhanced treatment options and easy discharge from acute care settings, as traditional hemodialysis at the centers could be related to recovery times after dialysis and increased treatment period due to transportation. 3-day dialysis services are provided at on-site dialysis in the SNFs, which required 17% lower treatment time than daily dialysis and reduces transportation-related hassles.

The transportation constraints related to dialysis centers are expected to boost the demand for the market over the forecast period. Patients receiving dialysis at dialysis centers are expected to require round-trip transportation to their clinic three times each week. This can be stressful for individuals as well as expensive for SNFs. There are several economic challenges including transportation costs, as the cost of transportation is not covered under Medicare, and time is spent arranging, transporting, and coordinating.

Both hemodialysis and peritoneal dialysis are covered under Medicare. Around 80% of the total costs for treatment are covered under Medicare. Moreover, training sessions for patients opting for home dialysis are covered under Medicare depending on the type of dialysis. Medicare Part A (Hospital Insurance) covers inpatient dialysis services only if the patient is admitted to a Medicare-approved facility, including hospitals, SNFs, hospice care, and home healthcare. The premiums for Medicare Part A are usually paid under Medicare taxes while working. In 2022, the patients are paying USD 1,556 deductible per benefit period.

The COVID-19 pandemic positively impacted the market owing to the reduction in unnecessary hospitalization of ESRD patients and the shifting of them to the SNFs. The demand for on-site dialysis in the SNFs increased due to the risks of getting exposed to the virus associated with the transportation of patients to the in-center dialysis. According to the CDC, in April 2020, around 47% of patients on dialysis in a Maryland skilled nursing facility tested positive for COVID-19 compared to 16% of patients not receiving treatment.

Region Insights

Based on region, the market is segmented into Northeast, Southeast, Southwest, Midwest, and West. The Midwest segment held the largest market share in 2022 and is expected to grow at the fastest rate during the forecast period. The rising prevalence of ESRD in the region is expected to boost the demand for dialysis services in the region. According to the annual report of the U.S. Renal Data System 2022, in 2020, Michigan, Minnesota, North Dakota, South Dakota, and Wisconsin reported 49,651 prevalent ESRD patients, and Missouri, Iowa, Nebraska, and Kansas reported around 28,307 prevalent ESRD patients.

U.S. SNF based dialysis market share, by region, 2022 (%)

Moreover, the southeast region is expected to witness the fastest growth during the forecast period owing to the rising utilization of these services at SNFs by ESRD patients. As per the annual report of the U.S. Renal Data System 2022, around 69.4% of ESRD patients opted for dialysis for treatment, and around 30.6% of patients opted for functioning transplants. In-center hemodialysis services were the most frequently utilized therapy for the treatment of ESRD in the region.

The West region is expected to witness significant growth during the forecast period. This can be attributed to the rising initiatives by the SNFs in the region to offer on-site dialysis services. For instance, in September 2019, Brookdale Senior Living collaborated with Dialyze Direct to offer on-site dialysis services at four SNFs in Texas. Dialyze Direct is offering on-site dialysis services at Brookdale Willowbrook Place, Brookdale Galleria, Brookdale Patriot Heights, and Brookdale Lakeway in Texas.

Key Companies & Market Share Insights

The companies are adopting various strategies, including the launch of advanced services, seeking national accreditations, and geographic expansion. Several facilities are offering specialized services to a specific cohort. For instance, in February 2021, MediLodge partnered with DaVita Kidney Care to provide on-site dialysis services to patients with long-term skilled nursing care and rehabilitative care. Some prominent players in the U.S. SNF-based dialysis market include:

  • Genesis Healthcare

  • Brickyard Healthcare (Formerly Golden LivingCenters)

  • Plaza Healthcare

  • Carespring

  • Generations Healthcare Network

  • Arbors Of Ohio

  • Medilodge

  • The Alden Network

  • Avalon Health Care

  • Batavia Nursing Care Center

U.S. SNF Based Dialysis Market Report Scope

Report Attribute

Details

Revenue forecast in 2030

USD 4.5 billion

Growth rate

CAGR of 6.22% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Region

Country scope

U.S.

Key companies profiled

Genesis Healthcare; Brickyard Healthcare (Formerly Golden LivingCenters); Plaza Healthcare; Carespring; Generations Healthcare Network; Arbors Of Ohio; MediLodge; The Alden Network; Avalon Health Care; Batavia Nursing Care Center

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

U.S. SNF Based Dialysis Market Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. SNF based dialysis market report based on region:

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • Northeast

    • Southeast

    • Southwest

    • Midwest

    • West

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.